articles+ search results

441 articles+ results

View results as:
Number of results to display per page

1. Cost-effectiveness of reducing children's sedentary time and increasing physical activity at school: the Transform-Us! intervention.

2. Which parents provide zero-alcohol beverages to adolescents? A survey of Australian parents' practices and intentions.

3. Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial

4. Letter to the editor: Poor sensitivity of anti‐nucleocapsid antibody in detecting prior COVID‐19 in vaccinated solid organ transplant recipients.

5. Left Atrial Function in Patients with Titin Cardiomyopathy.

6. d-Amino acids: new clinical pathways for brain diseases.

7. Earthquake early warning in Central America: The societal perspective.

8. Intraprofessional collaboration among graduate and undergraduate nursing students: A simulated pilot project.

9. Innovative Technologies in CNS Trials: Promises and Pitfalls for Recruitment, Retention, and Representativeness.

12. Patient‐reported outcome measures and patient engagement in heart failure clinical trials: multi‐stakeholder perspectives.

13. Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial.

14. Percentage of Adults Aged 18-64 Years Who Used Telemedicine in the Past 12 Months, by Sex and Health Insurance Coverage -- National Health Interview Survey, United States 2021.

15. Patterns of failure in pediatric medulloblastoma and implications for hippocampal sparing.

16. Implementation of a Web-Based Communication System for Primary Care Providers and Cancer Specialists.

17. Volume of subcortical brain regions in social anxiety disorder: mega-analytic results from 37 samples in the ENIGMA-Anxiety Working Group

18. Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial.

19. Evaluation of left cardiac chamber function with cardiac magnetic resonance and association with outcome in patients with systemic sclerosis.

20. 6‐month antibody kinetics and durability after four doses of a SARS‐CoV‐2 vaccine in solid organ transplant recipients.

21. PASC in Solid Organ Transplant Recipients With Self-reported SARS-CoV-2 Infection

22. Genetic diversity fuels gene discovery for tobacco and alcohol use

23. PART is part of SNAP‐MCI.

24. Drug therapy, imaging, and other aspects of clinical management change after Alzheimer's biomarker testing in routine practice: Findings from the IMPACT‐AD BC study.

25. Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis

27. Antibody response to a third dose of SARS‐CoV‐2 vaccine in heart and lung transplant recipients.

28. Patient and Healthcare Provider Perspectives on the Implementation of a Web-Based Clinical Communication System for Cancer: A Qualitative Study.

29. An innovative interprofessional education simulation for athletic training and prelicensure nursing students: Development, implementation, and student perspectives.

30. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial

31. Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External Validation

32. The impact of Mendelian sleep and circadian genetic variants in a population setting.

33. Which drinkers have changed their alcohol consumption due to energy content concerns? An Australian survey.

34. Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination

35. Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS‐CoV‐2 vaccines in solid organ transplant recipients: A case series.

36. Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

37. Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

38. 210.5: Differential Immunogenicity of mRNA-1273 Versus BNT162b2 as a Third Vaccine Dose for Solid Organ Transplant Recipients Seronegative After Two BNT162b2 Doses.

39. 230.6: Ad.26.COV2.S Versus BNT162b2 or mRNA-1273 as a Third Dose in Solid Organ Transplant Recipients Seronegative After 2-dose mRNA Vaccination

41. 330.4: SARS-coV-2 Antibody Response to a Third Dose of Homologous mRNA Vaccination in Liver Transplant Recipients

43. Location-specific psychosocial and environmental correlates of physical activity and sedentary time in young adolescents: preliminary evidence for location-specific approaches from a cross-sectional observational study.

44. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

45. A multi-layer functional genomic analysis to understand noncoding genetic variation in lipids

46. Reduced calcium levels and accumulation of abnormal insulin granules in stem cell models of HNF1A deficiency.

47. Improved humoral immunogenicity with mRNA‐1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses.

48. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

49. Levels of Parental Drinking in the Presence of Children: An Exploration of Attitudinal Correlates.

50. New Directions in Feminism and Global Race Studies: A Book Conversation.

52. Left Atrial Strain Has Superior Prognostic Value to Ventricular Function and Delayed-Enhancement in Dilated Cardiomyopathy.

53. Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients.

54. Should we "just stick to the facts"? The benefit of controversial conversations in classrooms.

55. Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure

56. A novel air microfluidics-enabled soft robotic sleeve: Toward realizing innovative lymphedema treatment.

57. Improved Antibody Response After a Fifth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

58. Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept

60. Six-month Antibody Kinetics and Durability After 3 Doses of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

61. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

62. Infectious diseases, comorbidities and outcomes in hospitalized people who inject drugs (PWID) infections in persons who inject drugs.

63. Genetic variants associated with longitudinal changes in brain structure across the lifespan

65. High Levels of Sedentary Time in Patients with COVID-19 after Hospitalisation.

66. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

67. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

68. Rare missense variants in Tropomyosin‐4 (TPM4) are associated with platelet dysfunction, cytoskeletal defects, and excessive bleeding

69. Advancing social inclusion of people with disabilities through awareness and training activities: A collaborative process between community partners and researchers.

70. Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination With Ad.26.COV2.S in Solid Organ Transplant Recipients: A Case Series

71. Large-scale migration into Britain during the Middle to Late Bronze Age

72. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

73. Six-month Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients

74. Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics

75. The power of genetic diversity in genome-wide association studies of lipids

76. SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients.